Unknown

Dataset Information

0

The IL-33/ST2 pathway: therapeutic target and novel biomarker.


ABSTRACT: For many years, the interleukin-1 receptor family member ST2 was an orphan receptor that was studied in the context of inflammatory and autoimmune disease. However, in 2005, a new cytokine--interleukin-33 (IL-33)--was identified as a functional ligand for ST2. IL-33/ST2 signalling is involved in T-cell mediated immune responses, but more recently, an unanticipated role in cardiovascular disease has been demonstrated. IL-33/ST2 not only represents a promising cardiovascular biomarker but also a novel mechanism of intramyocardial fibroblast-cardiomyocyte communication that may prove to be a therapeutic target for the prevention of heart failure.

SUBMITTER: Kakkar R 

PROVIDER: S-EPMC4277436 | biostudies-literature | 2008 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Kakkar Rahul R   Lee Richard T RT  

Nature reviews. Drug discovery 20081001 10


For many years, the interleukin-1 receptor family member ST2 was an orphan receptor that was studied in the context of inflammatory and autoimmune disease. However, in 2005, a new cytokine--interleukin-33 (IL-33)--was identified as a functional ligand for ST2. IL-33/ST2 signalling is involved in T-cell mediated immune responses, but more recently, an unanticipated role in cardiovascular disease has been demonstrated. IL-33/ST2 not only represents a promising cardiovascular biomarker but also a n  ...[more]

Similar Datasets

| S-EPMC6164146 | biostudies-literature
| S-EPMC6207585 | biostudies-other
| S-EPMC11364135 | biostudies-literature
| S-EPMC4760343 | biostudies-other
| S-EPMC6050508 | biostudies-literature
| S-EPMC7180392 | biostudies-literature
| S-EPMC10714644 | biostudies-literature
| S-EPMC7746527 | biostudies-literature
| S-EPMC4284762 | biostudies-literature
| S-EPMC4985267 | biostudies-literature